Related Experiment Video
Updated: Nov 14, 2025

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
Aortic Thrombosis in the Course of Covid-19 Disease; Two Rare Cases
Ahmet Rıfkı Çora1, Ersin Çelik1, Kadir Burhan Karadem2
1Isparta City Hospital Cardiovascular Surgery Clinic, Isparta, Turkey.
Insights
Severe COVID-19 can cause aortic thrombosis, a rare but deadly vascular complication. This study highlights two fatal cases, emphasizing the need to consider aortic thrombosis in affected patients with circulatory issues.
Area of Science:
- Vascular Surgery
- Infectious Diseases
- Cardiology
Background:
- Acute aortic thrombosis and aortoiliac thrombus are rare conditions associated with high mortality.
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, or COVID-19, can induce a hyperinflammatory and hyperimmune state.
- This state may lead to hypercoagulability and subsequent thrombotic events.
Observation:
- Two COVID-19 positive patients presented with rare aortic thrombotic events.
- Diagnostic computerized tomographic angiography revealed total aortic thrombosis below the renal arteries in one patient and a floating aortic thrombus in the other.
- Both patients experienced clinical deterioration despite initial medical management.
Findings:
- Despite medical therapies, both patients died before surgical intervention could be performed.
- The cases illustrate a severe thrombotic complication of COVID-19 affecting the vascular system.
Implications:
- COVID-19 impacts not only the pulmonary and inflammatory systems but also the coagulation and vascular systems.
- Aortic thrombosis should be considered in COVID-19 patients presenting with impaired peripheral circulation.
- Early recognition and management strategies for vascular complications in COVID-19 patients are crucial.
Objective:
Acute aortic thrombosis and floating aortailiac thrombus are infrequent clinical conditions with high morbidity and mortality rates. It was observed that; SARS-CoV-2 coronavirus disease (Covid-19) caused a hyperinflammation and hyperimmune state and these conditions can result in a hypercoagulation and eventually thrombotic events might occur.
Methods:
Here we presented two covid-19 positive patients with rare aortic thrombotic events.
Results:
Two patients underwent emergent diagnostic tests including computerized tomographic angiography. Total aortic thrombosis just below the renal arising point was evaluated in one patient, and aortic floating thrombus was evaluated in other patient. But despite initial medical therapies, the clinical conditions of the cases worsened and both patients died while on medical therapy before planned surgical intervention applied.
Conclusions:
Covid-19 is not only the disease of lungs and inflammatory system also the disease of coagulation and vascular system. Aortic thrombosis is rare and must be kept in mind in Covid-19 patients with peripheral circulation impairment.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation I: Introduction
Thoracic Aorta
Endocarditis II: Clinical Features of Infective Endocarditis
Aortic Regurgitation III: Medical Management